← Back to Clinical Trials
Recruiting NCT06154356

Action Observation and Motor Imagery Therapy in Parkinson's Disease

Trial Parameters

Condition Parkinson's Disease
Sponsor Karamanoğlu Mehmetbey University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 54
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2023-12-14
Completion 2026-06
Interventions
Action observation and motor imagery therapy for rehabilitationSham action observation and motor imagery therapy for rehabilitation

Brief Summary

In recent years, motor imagery (MI) and action observation (AO) therapy strategies have been used in rehabilitation programs to increase motor learning in Parkinson's disease (PD). Visuomotor training strategies such as AO and MI therapy rely on the activity of the mirror neuron system to facilitate motor re-learning. Mirror neurons are activated during the performance of goal-directed actions, also when observing the same action and visualizing the action in the mind. The aim of this clinical trial is to test whether the application of AO and MI treatment in PD in addition to conventional rehabilitation programs has an additional effect on Balance, Functional Status and Quality of Life.

Eligibility Criteria

Inclusion Criteria: * Patients with a diagnosis of Parkinson's Disease * Hoehn and Yahr Stage 1-3 Exclusion Criteria: * Patients with cognitive dysfunction (those who cannot follow simple verbal instructions) * Patients with severe hearing problems * Patients with severe vision problems * Patients with additional musculoskeletal system pathology that will affect physical performance (such as amputation, severe joint mobility limitation, peripheral nerve damage) * Patients with uncontrolled hypertension and diabetes mellitus * Patients with a history of symptomatic lung disease (such as asthma, chronic obstructive pulmonary disease, emphysema) * Patients with a history of symptomatic cardiac disease (such as coronary artery disease, arrhythmia, heart failure)

Related Trials